Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #2909 on RedHill Biopharma Ltd (RDHL)
midastouch017
05/18/21 5:00 PM
#2911 RE: FRAKSTER #2909
THEY SAID APRIL 9TH IN THE COMING WEEKS FOR RESULTS.
The 464-patient global Phase 2/3 COVID-19 study is over 75% enrolled, with completion of enrollment expected in the coming weeks
RDHL plans to have Topline data in 2.5 months.